Serge Lepage

Featured in: Favicon

Articles

Angiotensin-Neprilysin Inhibition in Patients With Mildly Reduced or Preserved Ejection Fraction and Worsening Heart Failure:

Jul 4, 2023 | jacc.org | Robert J. Mentz |Jonathan Ward |Adrian F. Hernandez |Adrián Hernández |Serge Lepage

JACC Journals › JACC › Archives › Vol. 82 No. 1 AbstractBackgroundU.S. guidelines recommend consideration of sacubitril/valsartan in chronic heart failure (HF) and mildly reduced or preserved ejection fraction (EF). Whether initiation is safe and effective in EF >40% after a worsening heart failure (WHF) event is unknown.

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.